---
title: "Cholestyramine - Hyperlipidemia"
sidebar: mydoc_sidebar
permalink: db01432-mesh-d006949-1.html
toc: false 
---


Path ID: `DB01432_MESH_D006949_1`
{% include image.html url="images/db01432-mesh-d006949-1.png" file="db01432-mesh-d006949-1.png" alt="db01432-mesh-d006949-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D002164 | cholestyramine | Drug |
| CHEBI:3098 | bile acid | ChemicalSubstance |
| HP:0030985 | Decreased serum bile concentration | PhenotypicFeature |
| MESH:D006949 | Hyperlipidemia | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Cholestyramine | MOLECULARLY INTERACTS WITH | Bile Acid |
| Bile Acid | CORRELATED WITH | Decreased Serum Bile Concentration |
| Decreased Serum Bile Concentration | NEGATIVELY CORRELATED WITH | Hyperlipidemia |
|---------|-----------|---------|

Comment: Cholestyramine is a bile acid sequestrant (https://www.ebi.ac.uk/ols/ontologies/ncit/terms?iri=http://purl.obolibrary.org/obo/NCIT_C98148) and its ultimate action is to lower serum concentration of lipids, namely cholesterol, phospholipids, triglycerides, and cholesterol esters.

Reference: 
  - [https://go.drugbank.com/drugs/DB01432](https://go.drugbank.com/drugs/DB01432)
